Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of serum-free purified Vero rabies vaccine with Verorab and Imovax Rabies for pre-exposure prophylaxis in children and adults
2019-000973-22Phase 3
- Sponsor
- Sanofi
- Start
- Nov 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Purified Vero cell rabies vaccine in rabies (3 arms), sponsored by Sanofi. Primary endpoint: Participants with RVNA titer at least 0.5 IU/mL at Day 42.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2019-000973-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000973-22.